Therapy Areas: Respiratory
17 June 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has presented results of two analyses from a Phase 2 study of Stelara&...
17 June 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has presented new data from PsABio its ongoing, real-world study of ne...
17 June 2019 - - US-based orphan lung disease company Savara Inc. (NASDAQ: SVRA) has received disappointing top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an in...
14 June 2019 - - The US Food and Drug Administration has approved its PD-L1 IHC 22C3 pharmDx assay for expanded use, US-based Agilent Technologies Inc. (NYSE: A) said.
The assay is now appr...
13 June 2019 - - The US Food and Drug Administration has granted Breakthrough Device designation for ResistancePlus GC - expediting the path towards FDA clearance, Australia-based SpeeDx Pty...
13 June 2019 - - UK-based clinical-stage company ReViral Ltd has appointed Alex C. Sapir as chief executive officer, the company said.
Sapir was also elected to the board of directors....
Related Headlines